Researcher
Lindsey Devisscher
- Keywords:Pharmacology, gastroenterology, hepatology, Macrophages, Immunology, Immuno-oncology
- Disciplines:Gastro-enterology and hepatology not elsewhere classified, Pharmacology not elsewhere classified, Gastro-enterology, Hepatology, Inflammation, Innate immunity, Cancer therapy
Affiliations
- Department of Basic and Applied Medical Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Pharmacology (Department)
Member
From1 Aug 2018 → 30 Sep 2018 - Department of Internal medicine (Department)
Member
From1 Oct 2010 → 30 Sep 2018 - Department of Large Animal Surgery, Anaesthesia and Orthopaedics (Department)
Member
From1 Oct 2006 → 31 Jul 2008
Projects
1 - 10 of 17
- Osteopontin and bile duct-associated macrophages in primary sclerosing cholangitisFrom1 Jan 2023 → TodayFunding: FWO research project
- Tissue and cell culture core facilityFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- Cofunding core facility - Animalarium,Radiological and Radiobiological Techniques, Histology CoreFrom1 Nov 2022 → TodayFunding: BOF - research organisations
- PSMA beyond the prostate: exploring prostate-specific membrane antigen as a target in the treatment of late-stage malignancies of the thyroid, liver and the head and neckFrom1 Oct 2022 → TodayFunding: Nonprofit institution or equivalents
- SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomicsFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- White light laser-based confocal fluorescence lifetime imaging microscope for multi-parameter 3D live imagingFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapiesFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- NADPH OXIDASE 1 INHIBITION AS NEW THERAPEUTIC OPTION FOR HEPATOCELLULAR CARCINOMAFrom1 Jan 2022 → TodayFunding: Nonprofit institution or equivalents
- Immune profiling and the role of monocyte/macrophage populations in primary sclerosing cholangitis and related ulcerative colitisFrom1 Nov 2021 → TodayFunding: FWO fellowships
- Immune profiling and the role of monocyte/macrophage populations in primary sclerosing cholangitis and related ulcerative colitis.From1 Oct 2021 → 31 Oct 2021Funding: BOF - doctoral mandates
Publications
1 - 10 of 103
- Metallothioneins alter macrophage phenotype and represent novel therapeutic targets for acetaminophen-induced liver injury(2022)
Authors: Lindsey Devisscher, Sanne Van Campenhout, Sander Lefere, Sarah Raevens, Laurentijn Tilleman, Filip Van Nieuwerburgh, Hannelore P. Van Eeckhoutte, Anne Hoorens, Michael A. Lynes, Anja Geerts, et al.
Pages: 123 - 133 - Intensive lifestyle management improves steatosis and fibrosis in pediatric non-alcoholic fatty liver disease(2022)
Authors: Sander Lefere, Ellen Dupont, Ann De Guchtenaere, Stephanie Van Biervliet, Saskia Vande Velde, Xavier Verhelst, Lindsey Devisscher, Hans Van Vlierberghe, Anja Geerts, Ruth De Bruyne
Pages: 2317 - 2326.e4 - Adipose tissue insulin resistance is a determinant of disease severity in pediatric nonalcoholic fatty liver disease(2022)Volume: 76
Authors: Anneleen Heldens, Ellen Dupont, Lindsey Devisscher, Anja Geerts, Ruth De Bruyne, Xavier Verhelst, Hans Van Vlierberghe, Sander Lefere
Pages: S1534 - S1535 - Combined therapy with a CCR2/CCR5 antagonist and FGF21 analogue synergizes in ameliorating steatohepatitis and fibrosis(2022)
Authors: Tobias Puengel, Sander Lefere, Jana Hundertmark, Marlene Kohlhepp, Christian Penners, Frederique Van de Velde, Bruno Lapauw, Anne Hoorens, Lindsey Devisscher, Anja Geerts, et al.
- Maternal and perinatal risk factors for pediatric nonalcoholic fatty liver disease : a systematic review(2022)
Authors: Ilya Querter, Nele Pauwels, Ruth De Bruyne, Ellen Dupont, Xavier Verhelst, Lindsey Devisscher, Hans Van Vlierberghe, Anja Geerts, Sander Lefere
Pages: 740 - 755 - The neurogliovascular unit in hepatic encephalopathy(2021)
Authors: Wouter Claeys, Lien Van Hoecke, Sander Lefere, Anja Geerts, Xavier Verhelst, Hans Van Vlierberghe, Helena Degroote, Lindsey Devisscher, Roosmarijn Vandenbroucke, Christophe Van Steenkiste
- Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models(2021)
Authors: Helena Degroote, Sander Lefere, Astrid Vandierendonck, Bart Vanderborght, Tim Meese, Filip Van Nieuwerburgh, Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe, Lindsey Devisscher
Pages: 562 - 577 - NOX1 inhibition attenuates the development of a proU+2010tumorigenic environment in experimental hepatocellular carcinoma(2021)
Authors: Aster Vandierendonck, Helena Degroote, Bart Vanderborght, Xavier Verhelst, Anja Geerts, Lindsey Devisscher, Hans Van Vlierberghe
- The gutU+2013liver axis in chronic liver disease : a macrophage perspective(2021)
Authors: Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher
- Dataset on transcriptomic profiling of cholestatic liver injury induced by food additives and a cosmetic ingredient(2021)
Authors: Eva Gijbels, Lindsey Devisscher, Mathieu Vinken